Consistent with these previous studies, we showed that RIOK2 expression was significantly correlated with a worse outcome in TSCC patients and that a decrease in RIOK2 expression affected cell growth in oral cancer cell lines. The gene discussed is RIOK2; the disease is lip and oral cavity carcinoma.